Recent and current advances in PET/CT imaging in the field of predicting epidermal growth factor receptor mutations in non-small cell lung cancer

Tyrosine kinase inhibitors (TKIs) are a significant treatment strategy for the management of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) mutation status. Currently, EGFR mutation status is established based on tumor tissue acquired by biopsy or resection, so there...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Na, Yan, Gang, Wu, Yuhui, Wang, Li, Wang, Yang, Xiang, Yining, Lei, Pinggui, Luo, Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582655/
https://www.ncbi.nlm.nih.gov/pubmed/36276079
http://dx.doi.org/10.3389/fonc.2022.879341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9582655/
https://www.ncbi.nlm.nih.gov/pubmed/36276079
http://dx.doi.org/10.3389/fonc.2022.879341

Ejemplares similares